Allergic rhinitis and associated risk of migraine among children: a nationwide population-based cohort study

I-Chung Wang1, Jeng-Dau Tsai2,3, Cheng-Li Lin4,5

  • 1Children's Hospital, China Medical University Hospital, Taichung, Taiwan.

Insights

Children with allergic rhinitis (AR) have a significantly higher risk of developing migraine. This study highlights the need for increased physician awareness of migraine symptoms in children diagnosed with AR.

Area of Science:

  • Pediatric Neurology
  • Allergy and Immunology
  • Epidemiology

Background:

  • Allergic rhinitis (AR) is linked to increased migraine frequency in adults.
  • Migraine can affect children and persist into adulthood.

Purpose of the Study:

  • To investigate the incidence and risk of migraine in children diagnosed with allergic rhinitis (AR).

Main Methods:

  • A population-based cohort study included 461,850 children with AR and 460,718 controls from 2000-2007.
  • Migraine incidence, hazard ratios (HRs), and confidence intervals (CIs) were measured by the end of 2008.

Main Results:

  • Children with AR showed a 3.2-fold higher migraine incidence (11.4 per 10,000 person-years) versus controls (3.49 per 10,000 person-years).
  • The risk was elevated in boys, children under 6, and those with more frequent AR-related medical visits (HR 14.8 for >4 visits).
  • Highest migraine risk occurred within the first year post-AR diagnosis (HR 4.89), with a higher likelihood of migraine without aura.

Conclusions:

  • Children with AR exhibit a greater incidence and subsequent risk of migraine.
  • Healthcare providers should maintain heightened awareness for migraine symptoms in pediatric patients with AR.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Allergic Reactions02:06

Allergic Reactions

Overview
33.6K
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin,...
177
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.3K